Abbott India Limited
Abbott India Limited: A Deep Dive into its Robust Forecast and Valuation Outlook Amidst a Thriving Indian Pharma Market
Mumbai, India – September 27, 2025 – Abbott India Limited (NSE: ABBOTINDIA), a prominent player in the Indian pharmaceutical sector, is exhibiting a robust financial trajectory and a promising valuation outlook. Propelled by strong Q1 FY2025-2026 results and strategic market maneuvers, the company continues to solidify its position in the rapidly expanding